Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06986161 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals

Study acronym: MG3
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing
    • Final enrollment: 33 participants (planned 30)
    • Primary completion date changed from estimate of Apr 13, 2026 to Jul 6, 2026
    • Site details revised
    v3
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.
Trial Details
NCT Number NCT06986161
Lead Sponsor Clinical Nutrition Research Center, Illinois Institute of Technology
Collaborators: National Mango Board
Conditions
(from sponsor)		 Pre Diabetes
Related terms Glucose Intolerance
Enrollment 33 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov